Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials
media
posted on 2022-10-18, 14:17 authored by Adis journals on behalf of, Jonathan I. Silverberg, Mark Boguniewicz, Jon Hanifin, Kim A. Papp, Haixin Zhang, Ana B. Rossi, Noah A. LevitArticle full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
The above infographic represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2022.
